Biomedical Engineering Reference
In-Depth Information
plenty of scope for entrepreneurial scientists to develop applications
for commercialization, but they have to have the networks,
collaborators, investors and initiative to see where any marketable
applications might be. The pharmaceutical model might be more
lucrative in the long term but the costs of establishing in-house
processing are somewhat prohibitive without adequate external
investment. Self-improvement appears to be the fastest growing area
of commercial application in the adult stem cell sciences to date, but
this is risky for newly developing techniques where the numbers of
people willing to participate are low and adequate knowledge about
adverse events has not been established. Still, as the market for stem
cell tourism shows, there are always going to be individuals keen to
experiment and as word spreads about successful techniques then
the market will continue developing. Adult stem cells have so far
shown a wide range of commercial prospects, and it appears to be
more or less a matter of time before an increasing number of clinical
applications are readily available in the developed world.
References
Barry, F. and Murphy, J. (2004) 'Mesenchymal stem cells: clinical
applications and biological characterization',
International Journal of
Biochemistry and Cell Biology
,
36 (4): 568-84.
Bianco, P., Robey, P. and Simmons, P. (2008) 'Mesenchymal stem cells:
revisiting history, concepts and assays',
Cell Stem Cell
,
2 (4): 313-19.
Billings, E. and May, J. (1989) 'Historical review and present status of free
fat graft autotransplantation in plastic and reconstructive surgery',
Journal of Plastic and Reconstructive Surgery
, 83: 368-81.
Blanplan, C., Horsely, V. and Fuchs, E. (2007) 'Epithelial stem cells: turning
over new leaves',
Cell
, 128 (3): 445-58.
Bortin, M. (1970) 'A compendium of reported human bone marrow
transplants',
Transplantation
,
9 (6): 571-89.
Brown, N. and Kraft, A. (2006) 'Blood ties: banking the stem cell promise',
Technology Analysis and Strategic Management
,
18 (3-4): 317-27.
Cairo, M. and Wagner, J. (1997) 'Placental and/or umbilical cord blood: an
alternative source of haematopoietic stem cells for transplantation',
Blood
,
90 (12): 4665-78.
